In this work, we found a decreased presence of CD3+ cells, representing T-cells, in adenomas and adenocarcinomas compared to controls, as well as reduced presence of CD18+ cells, representing histiocytes, in adenomas compared to controls. The gene discussed is ITGB2; the disease is adenocarcinoma.